| Pembrolizumab plus ipilimumab following anti-PD-1/L1 failure in melanoma DJ Olson, Z Eroglu, B Brockstein, AS Poklepovic, M Bajaj, S Babu, ... Journal of Clinical Oncology 39 (24), 2647, 2021 | 123 | 2021 |
| Basic principles of viscoelastic testing T Carll, GD Wool Transfusion 60, S1-S9, 2020 | 75 | 2020 |
| Randomized phase II trial and tumor mutational spectrum analysis from cabozantinib versus chemotherapy in metastatic uveal melanoma (Alliance A091201) JJ Luke, DJ Olson, JB Allred, CA Strand, R Bao, Y Zha, T Carll, ... Clinical Cancer Research 26 (4), 804-811, 2020 | 49 | 2020 |
| Significant antitumor activity for low-dose ipilimumab (IPI) with pembrolizumab (PEMBRO) immediately following progression on PD1 Ab in melanoma (MEL) in a phase II trial. D Olson, JJ Luke, AS Poklepovic, M Bajaj, E Higgs, TC Carll, B Labadie, ... Journal of Clinical Oncology 38 (15_suppl), 10004-10004, 2020 | 27 | 2020 |
| Refractory vaccine‐induced immune thrombotic thrombocytopenia (VITT) managed with delayed therapeutic plasma exchange (TPE) A Major, T Carll, CW Chan, C Christenson, F Aldarweesh, GD Wool, ... Journal of Clinical Apheresis 37 (1), 117-121, 2022 | 23 | 2022 |
| Phase II trial of pembrolizumab (pembro) plus 1 mg/kg ipilimumab (ipi) immediately following progression on anti-PD-1 Ab in melanoma (mel). D Olson, JJ Luke, S Hallmeyer, M Bajaj, T Carll, T Krausz, Y Zha, ... Journal of Clinical Oncology 36 (15_suppl), 9514-9514, 2018 | 21 | 2018 |
| Diagnosis and treatment of mixed phenotype (T-myeloid/lymphoid) acute leukemia with novel ETV6-FGFR2 rearrangement T Carll, A Patel, B Derman, E Hyjek, A Lager, P Wanjari, J Segal, ... Blood Advances 4 (19), 4924-4928, 2020 | 15 | 2020 |
| Assessment of consistency between peer-reviewed publications and clinical trial registries LW Sun, DJ Lee, JA Collins, TC Carll, K Ramahi, SJ Sandy, JG Unteriner, ... JAMA ophthalmology 137 (5), 552-556, 2019 | 10 | 2019 |
| Heterotopic gastrointestinal cyst of the oral cavity radiology–pathology correlation DT Ginat, T Carll, FM Baroody Head and Neck Pathology 13, 668-670, 2019 | 9 | 2019 |
| Transcriptional analysis of metastatic uveal melanoma survival nominates NRP1 as a therapeutic target R Bao, O Surriga, DJ Olson, JB Allred, CA Strand, Y Zha, T Carll, ... Melanoma research 31 (1), 27-37, 2021 | 8 | 2021 |
| Hyperhemolysis in a patient with sickle cell disease and recent SARS‐CoV‐2 infection, with complex auto‐and alloantibody work‐up, successfully treated with tocilizumab C Fuja, V Kothary, TC Carll, S Singh, P Mansfield, GD Wool Transfusion 62 (7), 1446-1451, 2022 | 7 | 2022 |
| Viscoelastic testing: Critical appraisal of new methodologies and current literature GD Wool, T Carll International Journal of Laboratory Hematology 45 (5), 643-658, 2023 | 5 | 2023 |
| Tissue contamination during transportation of formalin-fixed, paraffin-embedded blocks T Carll, C Fuja, T Antic, R Lastra, R Poon, R McGary, P Pytel American Journal of Clinical Pathology 158 (1), 96-104, 2022 | 5 | 2022 |
| An abdominal wall mass of exogenous insulin amyloidosis in setting of metastatic sarcoma T Carll, T Antic Journal of Cutaneous Pathology 47 (4), 406-408, 2020 | 4 | 2020 |
| Loss of 5-hydroxymethylcytosine expression is near-universal in B-cell lymphomas with variable mutations in epigenetic regulators KS Tanager, J Yu, BCH Chiu, TC Carll, AH Tatarian, P Riedell, S Smith, ... haematologica 107 (4), 966, 2022 | 2 | 2022 |
| Viscoelastic Testing Methods. T Carll Advances in Clinical Chemistry 117, 1-52, 2023 | 1 | 2023 |
| Validation and implementation of Aperio LV1 remote live view telepathology system for intraoperative frozen section diagnosis T Carll, F Siddiqui, M Agni, R Poon, C Nash, C Gettings, N Cipriani Journal of Pathology Informatics 14, 100194, 2023 | 1 | 2023 |
| Alloimmunization rates in transfused patients receiving anti‐CD47 antibody therapy T Carll, Z Mei, F Aldarweesh, GD Wool Transfusion 62 (4), 916-918, 2022 | 1 | 2022 |
| Correlates of overall survival (OS) in metastatic uveal melanoma (mUM) and a randomized trial of cabozantinib (cabo) versus chemotherapy (chemo). D Olson, R Bao, JB Allred, C Strand, Y Zha, TC Carll, B Labadie, ... Journal of Clinical Oncology 37 (15_suppl), 9506-9506, 2019 | 1 | 2019 |
| A severe case of delayed transfusion reaction in a patient with sickle cell disease while preparing for allogeneic stem cell transplant. M Amit, K Barsotti, T Carll, AV Desai, S Kaviany Pediatric Blood & Cancer, e31086-e31086, 2024 | | 2024 |
